annual Report 2009 - STRATEC Biomedical AG
annual Report 2009 - STRATEC Biomedical AG
annual Report 2009 - STRATEC Biomedical AG
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
10:38 11:40<br />
8.38 a.m.<br />
Talking to the<br />
doctor and giving<br />
blood<br />
Once the doctor has explained the<br />
background to the test, the blood sample<br />
is taken. This generally involves several<br />
milliliters of blood being taken in a test<br />
tube labeled with the patient’s name and<br />
a barcode enabling the sample to be<br />
clearly allocated.<br />
Depending on the type of test to be<br />
performed, a variety of analytical techniques<br />
and applications are used. One<br />
area that is still quite new is molecular<br />
diagnostics. This enables the genetic<br />
makeup of the individual pathogens<br />
present in the blood to be investigated.<br />
This way, more precise results can be<br />
obtained considerably faster. Invitek,<br />
a company acquired by <strong>STRATEC</strong> in<br />
April <strong>2009</strong>, specializes in molecular biological<br />
applications and has developed<br />
reagent systems enabling DNS and RNS<br />
to be separated from cell components not<br />
required for the analysis. Together with<br />
<strong>STRATEC</strong>, Invitek has further optimized<br />
the automation of this so-called purification<br />
process. As a result, <strong>STRATEC</strong> can<br />
now offer its customers and partners an<br />
additional, important component in its<br />
capacity as an OEM supplier of complete<br />
molecular diagnostic system solutions.